Why is Sanofi India falling/rising?

As of 31-Jul, Sanofi India Ltd's stock price is currently at 5,842.00, reflecting a decrease of 56.5 points or 0.96%. The stock has underperformed in the short term, with a 1-week decline of 1.22% and a 1-month drop of 5.83%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite this, the company has shown strong management efficiency with a high return on equity of 35.83% and a low debt-to-equity ratio, which may provide some support for the stock. Positive financial results, including significant growth in profit before tax and operating cash flow, suggest underlying strength, but the recent fall in delivery volume by 24.38% against the 5-day average indicates declining investor participation.
In the broader market context, Sanofi India's performance has mirrored the benchmark Sensex, both declining by 1.22% over the past week. However, while the Sensex has shown a year-to-date increase of 3.90%, Sanofi India has experienced a year-to-date decline of 4.22%. This divergence highlights the stock's struggles relative to the overall market. Furthermore, the high institutional holdings at 28.67% suggest that more informed investors are backing the company, yet the recent performance may deter retail investors, contributing to the stock's downward movement.